R&D + Strategic Partnering
for the Global Vaccine Industry

Dr. Akwar is the Science Advisor for Veterinary Sciences and AMR at the International Centre for Antimicrobial Resistance Solutions (ICARS). He leads the development and implementation of technical initiatives designed to generate evidence on AMR mitigation and enhance preventive health strategies...

Raiees Andrabi is an Associate Professor of Medicine, Perelman School of Medicine, Division of Infectious Diseases, Department of Medicine, University of Pennsylvania. Raiees Andrabi earned his PhD degree from the All India Institute of Medical Sciences in Biochemistry and performed his...

Dr. Berglund has over 25 years of experience in developing and evaluating novel vaccine technologies. As the original inventor of RNA vaccination he studied immune response, memory and protection against influenza and other viral infections. Previously, he was Executive Director of Research at...

Dr. Bhadelia is the founding director of Boston University’s Center on Emerging Infectious Diseases. She is a board-certified infectious diseases physician and an Associate Professor at the BU School of Medicine. She served as the Senior Policy Advisor for Global COVID-19 Response for the White...

Javier Castillo‑Olivares is a Senior Scientist in CEPI’s Laboratory Research and Innovations Department, contributing to global vaccine research and development through laboratory innovation, pre‑clinical evaluation, and cross‑functional scientific collaboration.His work focuses on understanding...

Dr. Ling CHEN received his medical degree from Shanghai Medical College (now affiliated with Fudan University) in 1984. He then entered the elite CUSBEA program and earned a Ph.D. in Biochemistry and Molecular Biology from Indiana University School of Medicine in the United States in 1992. After...

Heath Damron is Director of the Vaccine Development Center (VDC) at West Virginia University and Co-founder and Chief Scientific Officer of Montani Biotechnologies, Inc. He works in pre-clinical vaccine development, and the VDC collaborates with industry to evaluate experimental vaccines, including ...

Kathryn M. Edwards, MD, Professor of Pediatrics Emerita at Vanderbilt University in Nashville, TN, has led many of the pivotal clinical trials of vaccines licensed in the past several decades and has played a major role in their implementation.  She graduated from the University of Iowa College of...

Lauren is a reporter at POLITICO, with a focus on the FDA and pharmaceutical policy.She writes about how the world-renowned agency green-lights medical products and ensures their safety — and how they're ultimately adopted by American consumers. Her coverage spans from childhood vaccines to...

Huub Gelderblom is a physician-scientist who joined HVTN in 2019 and again in 2022. Huub has an MD, MSc and PhD from the University of Amsterdam, and an MPH from New York University. He has extensive experience working on HIV, hepatitis C, trachoma and SARS-CoV-2 in Europe, Africa, and the US. Huub ...

Pascal Geldsetzer is an Assistant Professor of Medicine at Stanford University and a Chan Zuckerberg Biohub Investigator. He has won an NIH New Innovator Award to investigate the feasibility of applying causal effect estimation techniques from the social sciences to clinical research questions. As...

Jon Heinrichs is Vice President and head of Discovery Science at IAVI, based in New York City. His responsibilities include advancing broadly neutralizing antibodies for HIV prevention and leading IAVI’s three laboratories, based in La Jolla, CA, Jersey City, NJ, and New Delhi, India. Prior to...

As Chief Operating Officer, Patricia is responsible for LimmaTech’s vaccine clinical programs. She joined  in 2014 in the Clinical Department and became part of LimmaTech’s Executive Management team in 2019. Prior to LimmaTech, Patricia held various roles in clinical research in several biotech...

Dr. John Mascola is Chief Scientific Officer of ModeX Therapeutics, a company developing innovative multispecific immunotherapies for cancer and immunological diseases. He is an accomplished physician-scientist, virologist and immunologist with over 25 years’ experience in research and development...

Dr. Jomana Musmar is a distinguished global policy expert and result-oriented leader with decades of intimate government experience within the U.S. Departments of Health and Human Services (HHS), Defense (DoD), and Agriculture (USDA). She excels in cross-functional coordination, strategic...

Dr. Elizabeth Norton, MPH, PhD: Dr. Norton is an Assistant Professor (tenure-track) at Tulane School of Medicine Department of Microbiology & Immunology. A major portion of her laboratory investigates LT-based adjuvants and proteins and mechanisms of vaccine efficacy related to age or disease...

Lisa Purcell has been an Entrepreneur-In-Residence and NewCo Chief Scientific Officer at Third Rock Ventures since May 2024. Her career has been dedicated to the development of therapies within the immunology and infectious disease areas. During the COVID-19 pandemic, she co-chaired the ACTIV...

Dr. Mehul S. Suthar, a leading expert in emerging viral infections, serves as Director of the Center for Childhood Infections and Vaccines at Emory University (2024) and Director of the Program on Pandemic Preparedness within the Emory Vaccine Center (member since 2012, Program Director since...

Dr. Lindsey Shields is an epidemiologist and global health leader with over 15 years of experience designing and implementing infectious disease surveillance, preparedness, and response programs in resource-limited settings worldwide. She currently serves as Deputy Director of Epidemic Preparedness ...

John A. Simon is a Founder and the Managing Partner/CEO of Total Impact Capital (TOTAL), an impact investing firm that structures, markets, and manages financing vehicles for underserved communities. The firm has partners in Washington, New York, Amsterdam, and Geneva and focuses on investments in...

Jim brings over three decades of experience developing and commercializing vaccines intended to treat or prevent diseases that impact children and adults around the world. During this time, he held significant leadership positions in the vaccine divisions of Pfizer, Novartis and Merck. Prior to...